JULIE GASTIER-FOSTER to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Xenograft Model Antitumor Assays.
Connection Strength
0.129
-
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Rep. 2019 11 05; 29(6):1675-1689.e9.
Score: 0.092
-
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. Nature. 2018 01 25; 553(7689):511-514.
Score: 0.020
-
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nat Genet. 2015 08; 47(8):864-71.
Score: 0.017